Shared genetic architecture between type 2 diabetes and COVID-19 severity

[1] Wiersinga WJ(2020)Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review JAMA 324 782-793

[2] Rhodes A(2020)COVID-19 and asthma: reflection during the pandemic Clin Rev Allergy Immunol 59 78-88

[3] Cheng AC(2021)Aging in COVID-19: vulnerability, immunity and intervention Ageing Res Rev 65 823-833

[4] Liu S(2020)Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Lancet Diabetes Endocrinol 8 1574-1581

[5] Zhi Y(2020)Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy JAMA 323 2012-2022

[6] Ying S(2020)COVID-19 in critically ill patients in the Seattle Region-Case Series N Engl J Med 382 813-822

[7] Chen Y(2020)Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study Lancet Diabetes Endocrinol 8 934-943

[8] Klein SL(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 180 2195-2198

[9] Garibaldi BT(2020)Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California JAMA 323 29-33

[10] Holman N(2020)Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy J Crit Care 58 471-480

[1] Wiersinga WJ(2020)Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review JAMA 324 782-793

[2] Rhodes A(2020)COVID-19 and asthma: reflection during the pandemic Clin Rev Allergy Immunol 59 78-88

[3] Cheng AC(2021)Aging in COVID-19: vulnerability, immunity and intervention Ageing Res Rev 65 823-833

[4] Liu S(2020)Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study Lancet Diabetes Endocrinol 8 1574-1581

[5] Zhi Y(2020)Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy JAMA 323 2012-2022

[6] Ying S(2020)COVID-19 in critically ill patients in the Seattle Region-Case Series N Engl J Med 382 813-822

[7] Chen Y(2020)Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study Lancet Diabetes Endocrinol 8 934-943

[8] Klein SL(2020)Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 180 2195-2198

[9] Garibaldi BT(2020)Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California JAMA 323 29-33

[10] Holman N(2020)Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy J Crit Care 58 471-480